HomeNewsBusinessSmall town India and freelancers will help Indian economy achieve the $5 trillion size: Report
Trending Topics

Small town India and freelancers will help Indian economy achieve the $5 trillion size: Report

While COVID-19 caused digital payment volumes to decline by more than 30 percent in the first half of 2020, in the months between September and December, the volumes jumped 40 to 45 percent.

January 12, 2021 / 19:39 IST
Story continues below Advertisement

Digital payments will continue to grow by 40 to 45 percent over the next two years with the blockchain-based business payments volume reaching $4.4 trillion by 2024, said Razorpay in the seventh edition of its fintech report released on January 12.

Tier two and three locations in the country are adopting digital payments quickly and will play a crucial role in driving the country a step towards a $5 trillion economy, the report added.

Story continues below Advertisement

Further Razorpay believes that the pandemic has opened fresh opportunities around digitising the supply chain and logistics business, which was always cash-dependent. Simultaneously, fresh business opportunities have opened up in digitising transactions for micro-entrepreneurs and freelancers, the report said.

Razorpay expects this market to become 50 percent of the overall workforce volume and attain a market size of $25 billion by 2025.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show